Indivior Pharmaceuticals, Inc. (INDV) Operating income 2022–2025
Indivior Pharmaceuticals, Inc. (INDV) annual operating income history from SEC filings — each fiscal year as reported.
$262.0MFY2025 · since FY2022: -$77.0M → $262.0M
| Fiscal year | Value | YoY |
|---|---|---|
| FY2025 | $262.0M | +589.5% |
| FY2024 | $38.0M | +125.0% |
| FY2023 | -$152.0M | -97.4% |
| FY2022 | -$77.0M | — |
Source: SEC XBRL filings · For reference only · Not investment advice
More INDV financial trends
INDV RevenueINDV Net incomeINDV Net marginINDV Gross profitINDV Gross marginINDV Operating marginINDV Operating cash flowINDV Free cash flowINDV Capital expendituresINDV Return on equityINDV Stock buybacksINDV Dividends paidINDV Total assetsINDV Total liabilitiesINDV Shareholders’ equityINDV overview →